Evidence map›Paper›PMID 32775775›Full record

ReviewAdvances in radiation oncology

Radiation Therapy Department Reorganization during the Coronavirus Disease 2019 (COVID-19) Outbreak: Keys to Securing Staff and Patients During the First Weeks of the Crisis and Impact on Radiation Therapy Practice from a Single Institution Experience.

Yazid Belkacemi, Gokoulakrichenane Loaganadane, Noémie Grellier, Gloria Fonteneau, Gaël Zaoui, Gabriele Coraggio, Asma Hadhri, Marie Adou, Jerôme Bendavid, Angela Boros and 12 more

Abstract readReview
In one paragraph

Review in Advances in radiation oncology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Review
  6. Effect of the COVID-19 pandemic on colorectal cancer care in France.The lancet. Gastroenterology & hepatology · 2021
    Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Yazid BelkacemiAssistance Publique Hopitaux de Paris (APHP), Department of Radiation Oncology and Henri Mondor Breast Center, Henri Mondor University Hospital, Creteil, France.
Gokoulakrichenane LoaganadaneAssistance Publique Hopitaux de Paris (APHP), Department of Radiation Oncology and Henri Mondor Breast Center, Henri Mondor University Hospital, Creteil, France.
Noémie GrellierAssistance Publique Hopitaux de Paris (APHP), Department of Radiation Oncology and Henri Mondor Breast Center, Henri Mondor University Hospital, Creteil, France.
Gloria FonteneauAssistance Publique Hopitaux de Paris (APHP), Department of Radiation Oncology and Henri Mondor Breast Center, Henri Mondor University Hospital, Creteil, France.
Gaël ZaouiAssistance Publique Hopitaux de Paris (APHP), Department of Radiation Oncology and Henri Mondor Breast Center, Henri Mondor University Hospital, Creteil, France.
Gabriele CoraggioAssistance Publique Hopitaux de Paris (APHP), Department of Radiation Oncology and Henri Mondor Breast Center, Henri Mondor University Hospital, Creteil, France.
Asma HadhriAssistance Publique Hopitaux de Paris (APHP), Department of Radiation Oncology and Henri Mondor Breast Center, Henri Mondor University Hospital, Creteil, France.
Marie AdouAssistance Publique Hopitaux de Paris (APHP), Department of Radiation Oncology and Henri Mondor Breast Center, Henri Mondor University Hospital, Creteil, France.
Jerôme BendavidAssistance Publique Hopitaux de Paris (APHP), Department of Radiation Oncology and Henri Mondor Breast Center, Henri Mondor University Hospital, Creteil, France.
Angela BorosAssistance Publique Hopitaux de Paris (APHP), Department of Radiation Oncology and Henri Mondor Breast Center, Henri Mondor University Hospital, Creteil, France.
Sahar GhithAssistance Publique Hopitaux de Paris (APHP), Department of Radiation Oncology and Henri Mondor Breast Center, Henri Mondor University Hospital, Creteil, France.
Kamel DebbiAssistance Publique Hopitaux de Paris (APHP), Department of Radiation Oncology and Henri Mondor Breast Center, Henri Mondor University Hospital, Creteil, France.
Pauline CadotAssistance Publique Hopitaux de Paris (APHP), Department of Radiation Oncology and Henri Mondor Breast Center, Henri Mondor University Hospital, Creteil, France.
Adeline BakAssistance Publique Hopitaux de Paris (APHP), Department of Radiation Oncology and Henri Mondor Breast Center, Henri Mondor University Hospital, Creteil, France.
Cindy Le BretAssistance Publique Hopitaux de Paris (APHP), Department of Radiation Oncology and Henri Mondor Breast Center, Henri Mondor University Hospital, Creteil, France.
Wissal HassaniAssistance Publique Hopitaux de Paris (APHP), Department of Radiation Oncology and Henri Mondor Breast Center, Henri Mondor University Hospital, Creteil, France.
Mathilde MahéAssistance Publique Hopitaux de Paris (APHP), Department of Radiation Oncology and Henri Mondor Breast Center, Henri Mondor University Hospital, Creteil, France.
Marie-Laure HervéAssistance Publique Hopitaux de Paris (APHP), Department of Radiation Oncology and Henri Mondor Breast Center, Henri Mondor University Hospital, Creteil, France.
Laurianne Colson-DurandAssistance Publique Hopitaux de Paris (APHP), Department of Radiation Oncology and Henri Mondor Breast Center, Henri Mondor University Hospital, Creteil, France.
Nhu Hanh ToAssistance Publique Hopitaux de Paris (APHP), Department of Radiation Oncology and Henri Mondor Breast Center, Henri Mondor University Hospital, Creteil, France.
Deng Feng LuoAssistance Publique Hopitaux de Paris (APHP), Department of Radiation Oncology and Henri Mondor Breast Center, Henri Mondor University Hospital, Creteil, France.
Aziz CherifAssistance Publique Hopitaux de Paris (APHP), Department of Radiation Oncology and Henri Mondor Breast Center, Henri Mondor University Hospital, Creteil, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeDuring the first weeks of the coronavirus disease 2019 (COVID-19) outbreak in France, it was necessary to clearly define organizational priorities in the radiation therapy (RT) departments. In this report, we focus on the urgent measures taken to reduce risk for both our staff and patients by reducing the number of patients receiving treatment. METHODS AND MATERIALS: We reviewed the fractionation schemes for all patients in our department, including those receiving treatment and those soon to start treatment. Our goals were to (1) decrease the number of patients coming daily to the hospital for RT, (2) adapt our human resources to continue patients' care in the department, and (3) help to cover understaffed COVID-19 sectors of the hospital.

resultsWe identified 50 patients who were receiving treatment (n = 6), were going to start radiation after CT scan simulation (n = 41), or for whom the CT scan was pending (n = 3). The majority were women (64%) treated for breast cancer (54%). RT was delayed for 22 (44%) patients. The majority were offered hormone therapy as "waiting therapy." Hypofractionation was considered in 21 (42%) patients mainly with breast cancer (18 of 21, 86%). The number of courses initially planned and replanned as a result of the COVID-19 outbreak during the period of March 15 to May 31, 2020, were 1383 and 683, respectively, which represented a reduction of 50% (including delayed sessions) that allowed our reorganization process.

conclusionsTo conserve resources during the pandemic, we successfully reduced the number of patients receiving treatment in a proactive fashion and adapted our organization to minimize the risk of COVID-19 contamination. Departments across the world may benefit from this same approach.

Identifiers

PMID32775775
PMCPMC7250781

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.